{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:13:10Z","timestamp":1760523190355},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T00:00:00Z","timestamp":1404000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T00:00:00Z","timestamp":1404000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00105-014-2757-8","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T01:45:56Z","timestamp":1407807956000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapie der Prurigo nodularis"],"prefix":"10.1007","volume":"65","author":[{"given":"C.","family":"Zeidler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,29]]},"reference":[{"key":"2757_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","volume":"123","author":"Bergasa","year":"1995","unstructured":"Bergasa NV, Alling DW, Talbot TL et al (1995) Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 123:161\u2013167","journal-title":"Ann Intern Med"},{"key":"2757_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2230.2009.03705.x","volume":"35","author":"Bruni","year":"2010","unstructured":"Bruni E, Caccialanza M, Piccinno R (2010) Phototherapy of generalized prurigo nodularis. Clin Exp Dermatol 35:549\u2013550","journal-title":"Clin Exp Dermatol"},{"key":"2757_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/dth.12026","volume":"26","author":"Cotes","year":"2013","unstructured":"Cotes MES, Swerlick RA (2013) Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus. Dermatol Ther 26:120\u2013134","journal-title":"Dermatol Ther"},{"key":"2757_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","volume":"24","author":"Darsow","year":"2010","unstructured":"Darsow U, Wollenberg A, Simon D et al (2010) ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 24:317\u2013328","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2757_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","volume":"25","author":"Davis","year":"2003","unstructured":"Davis MP, Frandsen JL, Walsh D et al (2003) Mirtazapine for pruritus. J Pain Symptom Manage 25:288\u2013291","journal-title":"J Pain Symptom Manage"},{"key":"2757_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","volume":"23","author":"Gencoglan","year":"2010","unstructured":"Gencoglan G, Inanir I, Gunduz K (2010) Therapeutic hotline: treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther 23:194\u2013198","journal-title":"Dermatol Ther"},{"key":"2757_CR7","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","volume":"19","author":"Gunal","year":"2004","unstructured":"Gunal AI, Ozalp G, Yoldas TK et al (2004) Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 19:3137\u20133139","journal-title":"Nephrol Dial Transplant"},{"key":"2757_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1468-3083.2010.03865.x","volume":"25","author":"Hammes","year":"2011","unstructured":"Hammes S, Hermann J, Roos S, Ockenfels HM (2011) UVB 308-nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis. J Eur Acad Dermatol Venereol 25:799\u2013803","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2757_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-4362.1990.tb03833.x","volume":"29","author":"Hann","year":"1990","unstructured":"Hann SK, Cho MY, Park YK (1990) UV treatment of generalized prurigo nodularis. Int J Dermatol 29:436\u2013437","journal-title":"Int J Dermatol"},{"key":"2757_CR10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1684\/ejd.2013.2169","volume":"23","author":"Luger","year":"2013","unstructured":"Luger T, Raeve L de, Gelmetti C et al (2013) Recommendations for pimecrolimus 1\u2009% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol 23:758\u2013766","journal-title":"Eur J Dermatol"},{"key":"2757_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jcpt.12005","volume":"38","author":"Mazza","year":"2013","unstructured":"Mazza M, Guerriero G, Marano G et al (2013) Treatment of prurigo nodularis with pregabalin. J Clin Pharm Ther 38:16\u201318","journal-title":"J Clin Pharm Ther"},{"key":"2757_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2340\/00015555-1353","volume":"92","author":"Phan","year":"2012","unstructured":"Phan NQ, Lotts T, Antal A et al (2012) Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venereol 92:555\u2013560","journal-title":"Acta Derm Venereol"},{"key":"2757_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2310\/7750.2009.08082","volume":"14","author":"Richards","year":"2010","unstructured":"Richards RN (2010) Update on intralesional steroid: focus on dermatoses. J Cutan Med Surg 14:19\u201323","journal-title":"J Cutan Med Surg"},{"key":"2757_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/09546630903386606","volume":"21","author":"Saraceno","year":"2010","unstructured":"Saraceno R, Chiricozzi A, Nistic\u00f2 SP et al (2010) An occlusive dressing containing betamethasone valerate 0.1\u2009% for the treatment of prurigo nodularis. J Dermatolog Treat 21:363\u2013366","journal-title":"J Dermatolog Treat"},{"key":"2757_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1365-4362.2003.01831.x","volume":"42","author":"Scheinfeld","year":"2003","unstructured":"Scheinfeld N (2003) The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 42:491\u2013495","journal-title":"Int J Dermatol"},{"key":"2757_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00105-009-1730-4","volume":"60","author":"Schulz","year":"2009","unstructured":"Schulz S, Metz M, Siepmann D et al (2009) Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie. Ergebnisse einer retrospektiv analysierten Fallserie. Hautarzt 60:564\u2013568","journal-title":"Hautarzt"},{"key":"2757_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/dth.12094","volume":"27","author":"Shintani","year":"2013","unstructured":"Shintani T, Ohata C, Koga H et al (2013) Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis. Dermatol Ther 27:135\u2013139","journal-title":"Dermatol Ther"},{"key":"2757_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/15569520701212340","volume":"26","author":"Shohrati","year":"2007","unstructured":"Shohrati M, Davoudi S-M, Keshavarz S et al (2007) Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol 26:249\u2013255","journal-title":"Cutan Ocul Toxicol"},{"key":"2757_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000355671","volume":"227","author":"Siepmann","year":"2013","unstructured":"Siepmann D, Lotts T, Blome C et al (2013) Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial. Dermatology 227:353\u2013360","journal-title":"Dermatology"},{"key":"2757_CR20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1610-0387.2008.06745_supp.x","volume":"6","author":"Siepmann","year":"2008","unstructured":"Siepmann D, Luger TA, St\u00e4nder S (2008) Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series. J Dtsch Dermatol Ges 6:941\u2013946","journal-title":"J Dtsch Dermatol Ges"},{"key":"2757_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2340\/00015555-0553","volume":"89","author":"St\u00e4nder","year":"2009","unstructured":"St\u00e4nder S, B\u00f6ckenholt B, Sch\u00fcrmeyer-Horst F et al (2009) Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol 89:45\u201351","journal-title":"Acta Derm Venereol"},{"key":"2757_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08005.x","volume":"4","author":"St\u00e4nder","year":"2012","unstructured":"St\u00e4nder S, Darsow U, Mettang T et al (2012) S2k-Leitlinie \u2013 Chronischer Pruritus. J Dtsch Dermatol Ges 4:S1\u2013S27","journal-title":"J Dtsch Dermatol Ges"},{"key":"2757_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1067\/mjd.2001.110059","volume":"44","author":"St\u00e4nder","year":"2001","unstructured":"St\u00e4nder S, Luger T, Metze D (2001) Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 44:471\u2013478","journal-title":"J Am Acad Dermatol"},{"key":"2757_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.0906-6705.2004.0178.x","volume":"13","author":"St\u00e4nder","year":"2004","unstructured":"St\u00e4nder S, Moormann C, Schumacher M et al (2004) Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 13:129\u2013139","journal-title":"Exp Dermatol"},{"key":"2757_CR25","first-page":"5","volume":"4","author":"St\u00e4nder","year":"2010","unstructured":"St\u00e4nder S, Siepmann D, Herrgott I et al (2010) Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 4:5","journal-title":"PLoS One"},{"key":"2757_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1346-8138.2007.00360.x","volume":"34","author":"Tamagawa-Mineoka","year":"2007","unstructured":"Tamagawa-Mineoka R, Katoh N, Ueda E, Kishimoto S (2007) Narrow-band ultraviolet B phototherapy in patients with recalcitrant nodular prurigo. J Dermatol 34:691\u2013695","journal-title":"J Dermatol"},{"key":"2757_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.0007-0963.2004.05889.x","volume":"150","author":"Winhoven","year":"2004","unstructured":"Winhoven SM, Coulson IH, Bottomley WW (2004) Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 150:786\u2013787","journal-title":"Br J Dermatol"},{"key":"2757_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000029943","volume":"13","author":"Zhai","year":"2000","unstructured":"Zhai H, Frisch S, Pelosi A et al (2000) Antipruritic and thermal sensation effects of hydrocortisone creams in human skin. Skin Pharmacol Appl Skin Physiol 13:352\u2013357","journal-title":"Skin Pharmacol Appl Skin Physiol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-2757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-014-2757-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-2757-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-014-2757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T01:06:34Z","timestamp":1652749594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-014-2757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,29]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1007\/s00105-014-2757-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,29]]},"assertion":[{"value":"29 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"709"}}